Hypothesis: It is time to reconsider phenotypes in hypertension

Journal of Clinical Hypertension

Volumn 12, Issue 5, 2010, Pages 350-356

  Orias, Marcelo ^a   Tabares, Aldo H ^b   Peixoto, Aldo J ^c,d  

^a Sanatorio Allende   (Argentina)

^b HOSPITAL PRIVADO   (Argentina)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; RENIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC TRAIT; HEART STROKE VOLUME; HUMAN; HYPERDYNAMIC HYPERTENSION; HYPERTENSION; HYPOTHESIS; ISOLATED DIASTOLIC HYPERTENSION; ISOLATED SYSTOLIC HYPERTENSION; PHENOTYPE; PREDOMINANTLY DIASTOLIC HYPERTENSION; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; REVIEW; AGE; BLOOD PRESSURE; COMPLICATION; FEMALE; GENETICS; HEART CONTRACTION; HEMODYNAMICS; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

AGE FACTORS; BLOOD PRESSURE; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION; MALE; MYOCARDIAL CONTRACTION; PHENOTYPE; YOUNG ADULT;

EID: 77953676698     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2010.00266.x     Document Type: Review

References (58)

1. Ezzati M, Lopez AD, Rodgers A. Selected major risk factors and global and regional burden of disease. Lancet. 2002, 360:1347-1360.
2. Burt VL, Whelton P, Roccella EJ. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995, 25:305-313.
3. Primatesta P, Brookes M, Poulter NR. Improved hypertension management and control: results from the health survey for England 1998. Hypertension. 2001, 38:827-832.
4. Schones DE, Zhao K. Genome-wide approaches to studying chromatin modifications. Nat Rev Genet. 2008, 9:179-191.
5. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001, 104:545-556.
6. Levy D, Ehret GB, Rice K. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009, 41:677-687.
7. Newton-Cheh C, Johnson T, Gateva V. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009, 41:666-676.
8. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007, 447:661-678.
9. Replicating genotype-phenotype associations. Nature. 2007, 447:655-660.
10. Harrap S. Blood pressure genetics: time to focus. J Am Soc Hypertens. 2009, 3:231-237.
11. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008, 300:924-932.
12. Mani A, Radhakrishnan J, Wang H. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science. 2007, 315:1278-1282.
13. The IDF consensus worldwide definition of the metabolic syndrome. Lancet. 2005, 366:1059-1062.
14. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001, 285:2486-2497.
15. Kahn R, Buse J, Ferrannini E. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005, 28:2289-2304.
16. Chobanian AV, Bakris GL, Black HR. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289:2560-2572.
17. Franklin SS, Khan SA, Wong ND. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation. 1999, 100:354-360.
18. Benetos A, Safar M, Rudnichi A. Pulse pressure: a predictor of long-term cardiovascular mortality in a french male population. Hypertension. 1997, 30:1410-1415.
19. Domanski M, Mitchell G, Pfeffer M. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (Mrfit). JAMA. 2002, 287:2677-2683.
20. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991, 265:3255-3264.
21. Staessen JA, Fagard R, Thijs L. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (SYST-EUR) Trial Investigators. Lancet. 1997, 350:757-764.
22. Liu L, Wang JG, Gong L. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens. 1998, 16:1823-1829.
23. Zintzaras E, Kitsios G, Kent D. Genome-wide scans meta-analysis for pulse pressure. Hypertension. 2007, 50:557-564.
24. Franklin SS, Pio JR, Wong ND. Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study. Circulation. 2005, 111:1121-1127.
25. Franklin SS, Gustin Wt, Wong ND. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997, 96:308-315.
26. O'Rourke MF, Vlachopoulos C, Graham RM. Spurious systolic hypertension in youth. Vasc Med. 2000, 5:141-145.
27. Mahmud A, Feely J. Spurious systolic hypertension of youth: fit young men with elastic arteries. Am J Hypertens. 2003, 16:229-232.
28. McEniery CM, Yasmin, Wallace S. Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension. 2005, 46:221-226.
29. Mallion JM, Hamici L, Chatellier G. Isolated systolic hypertension: data on a cohort of young subjects from a French working population (IHPAF). J Hum Hypertens. 2003, 17:93-100.
30. Saladini F, Dorigatti F, Santonastaso M. Natural history of hypertension subtypes in young and middle-age adults. Am J Hypertens. 2009, 22:531-537.
31. Galarza CR, Alfie J, Waisman GD. Diastolic pressure underestimates age-related hemodynamic impairment. Hypertension. 1997, 30:809-816.
32. Franklin SS, Larson MG, Khan SA. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001, 103:1245-1249.
33. Franklin SS, Jacobs MJ, Wong ND. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health And Nutrition Examination Survey (NHANES) III. Hypertension. 2001, 37:869-874.
34. Blank SG, Mann SJ, James GD. Isolated elevation of diastolic blood pressure. Real or artifactual? Hypertension. 1995, 26:383-389.
35. Pickering TG. Isolated diastolic hypertension. J Clin Hypertens (Greenwich). 2003, 5:411-413.
36. Hozawa A, Ohkubo T, Nagai K. Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama Study. Arch Intern Med. 2000, 160:3301-3306.
37. Strandberg T, Salomaa V, Vanhanen H. Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32 years. J Hypertens. 2002, 20:399-404.
38. Sesso HD, Stampfer MJ, Rosner B. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension. 2000, 36:801-807.
39. Glynn RJ, L'Italien GJ, Sesso HD. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension. 2002, 39:105-110.
40. Kelly TN, Gu D, Chen J. Hypertension subtype and risk of cardiovascular disease in Chinese adults. Circulation. 2008, 118:1558-1566.
41. Fang J, Madhavan S, Cohen H. Isolated diastolic hypertension: a favorable finding among young and middle-aged hypertensive subjects. Hypertension. 1995, 26:377-382.
42. Nielsen WB, Lindenstrom E, Vestbo J. Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens. 1997, 10:634-639.
43. Jimenez PM, Conde C, Casanegra A. Association of ACE genotype and predominantly diastolic hypertension: a preliminary study. J Renin Angiotensin Aldosterone Syst. 2007, 8:42-44.
44. Safar ME, Weiss YA, Levenson JA. Hemodynamic study of 85 patients with borderline hypertension. Am J Cardiol. 1973, 31:315-319.
45. Julius S, Esler M. Autonomic nervous cardiovascular regulation in borderline hypertension. Am J Cardiol. 1975, 36:685-696.
46. Lund-Johansen P. Haemodymnamics in early essential hypertension--still an area of controversy. J Hypertens. 1983, 1:209-213.
47. O'Donnell CJ, Lindpaintner K, Larson MG. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation. 1998, 97:1766-1772.
48. Franklin SS, Barboza MG, Pio JR. Blood pressure categories, hypertensive subtypes, and the metabolic syndrome. J Hypertens. 2006, 24:2009-2016.
49. Wu H, Xu J, Zhuo L. Comparison of risk factors associated with hypertension subtypes by classification tree method in Tongshan County of Jiangsu Province, China. Am J Hypertens. 2009, 22:1287-1294. Epub 2009 Oct 1
50. Widimsky J, Fejfarova M, Fejfar Z. Changes of cardiac output in hypertensive disease. Cardiologia. 1957, 31:381-389.
51. Julius S, Pascual AV, London R. Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation. 1971, 44:413-418.
52. Messerli FH, Frohlich ED, Suarez DH. Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines. Circulation. 1981, 64:760-764.
53. Julius S, Krause L, Schork NJ. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens. 1991, 9:77-84.
54. Jiang X, Srinivasan SR, Urbina E. Hyperdynamic circulation and cardiovascular risk in children and adolescents. The Bogalusa Heart Study. Circulation. 1995, 91:1101-1106.
55. Sorof JM, Poffenbarger T, Franco K. Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr. 2002, 140:660-666.
56. Esler M, Straznicky N, Eikelis N. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension. 2006, 48:787-796.
57. Fouad FM, Tarazi RC, Dustan HP. Hemodynamics of essential hypertension in young subjects. Am Heart J. 1978, 96:646-654.
58. Lund Johansen P. Essential hypertension: hemodynamic and therapeutic changes over 20 years. J Cardiovasc Pharmacol. 1991, 18:S1-S7.